Table 1 Associations between miR-125 expression and clinicopathological characteristics

Age (years)

0.621

 ≥ 45

33

15

18

 < 45

25

13

12

HPV 16/18 infection

0.301

 Positive

41

18

23

 Negative

17

10

7

Tumor size

0.031*

 < 4 cm

25

8

17

 ≥ 4 cm

33

20

13

Histology

0.397

 Squamous cell cancer

24

10

14

 Adenocarcinima and others

34

18

16

Differentiation

0.061

 Well and moderately

40

16

24

 Poor

18

12

6

FIGO

0.018*

 I

36

13

23

 II

22

15

7

Lymph node metastasis

0.923

 Negative

39

19

20

 Positive

19

9

10